An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639337 | PMC |
| http://dx.doi.org/10.1038/s41419-019-1725-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Publisher Correction: Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride.
Sci Rep
February 2020
Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
View Article and Find Full Text PDFCorrection: 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Cell Death Dis
July 2019
Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
View Article and Find Full Text PDFEpigenetically reprogramming of human embryonic stem cells by 3-deazaneplanocin a and sodium butyrate.
Int J Prev Med
April 2011
Department of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, United States of America.
Objectives: Infertility affects about 6.1 million women aged 15-44 in the United States. The leading cause of infertility in women is quantitative and qualitative defects in human germ-cell development (these sentences are not mentioned in introduction so it is not correct to mention in abstract, you can omit).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!